Abstract
Recent reports revealed a declining malaria burden, but non-malaria febrile illnesses (NMFIs) have either remained unchanged or increased. This study assessed the country-wide prevalence of NMFIs and their patterns across various malaria transmission settings in Mainland Tanzania. A cross-sectional study recruited patients aged ≥ 6 months from 86 health facilities in all 26 regions of Tanzania. All patients were tested for malaria using rapid diagnostic tests (RDTs) and the prevalence of NMFIs was determined for all patients with negative results. Logistic regression was used to determine factors associated with NMFIs. Of the 18,568 patients tested, 8,273 (44.6%) had NMFIs due to negative RDT results. Higher prevalence of NMFIs occurred in females (45.8%) than males (42.8%), adults (aged ≥ 15 years, with 50.6%) compared to under-fives (42.6%) and school children (aged 5 -< 15 years, 34.3%), and in very low (71.5%) compared to high transmission areas (33.9%). NMFIs were significantly more likely in females than in males (aOR = 1.14, 95% CI = 1.07–1.22), in very low transmission areas (aOR = 4.85, 95% CI = 4.42–5.33), adults (aOR = 1.60, 95% CI = 1.46–1.75) and under-fives (aOR = 1.60, 95% CI = 1.47–1.76). The findings show high prevalence of NMFIs overall, and higher prevalence and odds of NMFIs in females, under-fives and individuals from low and very low transmission areas. These groups should be targeted with appropriate point-of-care tests and treatment strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported in full by the Bill & Melinda Gates Foundation [grant number INV. 002202 and INV. 067322]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This large health facility survey was part of the MSMT project, whose protocol was reviewed and approved by the Medical Research Coordinating Committee (MRCC) of the National Institute for Medical Research (NIMR). Permission to conduct the study in the different regions was sought from the Presidents Office, Regional Administration and Local Government (PO-RALG). Before taking part in the survey verbal and written informed consent was sought and obtained from all participants or parents/guardians in the case of children.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵# Co-senior authors
Data Availability
The data used in this paper are available and can be obtained upon reasonable request from the corresponding author institutional approval by NIMR, and the signing of a data transfer agreement between the donor and recipient.
